{"id":50235,"date":"2022-10-28T18:01:49","date_gmt":"2022-10-28T16:01:49","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-research-antibodies-market-analysis-report-2022-2030-lucrative-opportunities-in-growing-demand-for-personalized-medicine-and-rising-focus-on-biomarker-discovery-researchandmarkets-com\/"},"modified":"2022-10-28T18:01:49","modified_gmt":"2022-10-28T16:01:49","slug":"global-research-antibodies-market-analysis-report-2022-2030-lucrative-opportunities-in-growing-demand-for-personalized-medicine-and-rising-focus-on-biomarker-discovery-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-research-antibodies-market-analysis-report-2022-2030-lucrative-opportunities-in-growing-demand-for-personalized-medicine-and-rising-focus-on-biomarker-discovery-researchandmarkets-com\/","title":{"rendered":"Global Research Antibodies Market Analysis Report 2022-2030: Lucrative Opportunities in Growing Demand for Personalized Medicine and Rising Focus on Biomarker Discovery – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Research Antibodies Market Size, Share & Trends Analysis Report by Product (Primary, Secondary), by Type, by Technology, by Source, by Application, by End-use, by Region, and Segment Forecasts, 2022-2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global research antibodies market size is expected to reach USD 2.21 billion by 2030, expanding at a CAGR of 4.93% from 2022 to 2030\n<\/p>\n

\nFactors driving the market include a rise in R&D activities undertaken by biopharmaceutical and biotechnology companies and increase in support from government authorities. Furthermore, expansion in the scope of neurobiology and stem cell research and the availability of technologically advanced antibody production methods are expected to propel market growth.\n<\/p>\n

\nAn increase in the number of collaborative initiatives undertaken by research institutes and various public and private entities for the promotion of cell-based research is fueling market growth. The trend is more prominent in established markets, such as North America, that have an established scientific infrastructure.\n<\/p>\n

\nFor instance, in March 2020, the Canadian government invested around USD 4.3 million in funds towards the Centre for Commercialization of Regenerative Medicine, which is involved in carrying out scientific studies based on cell regeneration.\n<\/p>\n

\nMoreover, in April 2021, the government announced an investment of USD 45 million over 3 years in Stem Cell Network to develop information, therapies, and technologies to benefit individuals living with chronic and severe illnesses such as COVID-19 and assess its long-term impact. Such initiatives are expected to encourage further adoption of antibody activities and enhance the growth prospects for the market.\n<\/p>\n

\nThe COVID-19 outbreak has created lucrative growth opportunities for the market. Several leading pharmaceutical companies are investing significantly in R&D for creating effective testing tools and increasing scientific understanding of the disease. The need for research antibodies has greatly increased as a result of these intense R&D operations for the development of novel vaccination and therapy techniques.\n<\/p>\n

\nAdditionally, a number of public and commercial entities are making significant efforts to fund the development of COVID-19 vaccines and therapeutics. For instance, in April 2020, Emergent BioSolutions, a biopharmaceutical company, received USD 14.5 million from the federal government to work on an antibody therapy study for COVID-19.\n<\/p>\n

\nResearch Antibodies Market Report Highlights<\/strong>\n<\/p>\n